© 2021 - Negotiamini. All Rights Reserved.
UK health and social care secretary, Matt Hancock has outlined the government’s commitment to bolster the UK life sciences sector and build on lessons from the COVID-19 pandemic.
During the Association of the British Pharmaceutical Industry (ABPI) annual conference last week, Hancock pledged £37 million for genomics projects and for data-driven initiatives delivered through the Genome UK Implementation Plan and the UK Functional Genomics Initiative, which was launched in September 2019.
WHY IT MATTERS
The pledge aims to make the UK a global leader in manufacturing for medicines, grow UK-based business and encourage investment. Through these investments, patients are set to benefit from better research, treatment, care and improved clinical decision-making.
Genomics England projects supporting the implementation of the Genome UK strategy will receive £17 million to explore the potential value of newborn sequencing, contributing to the increase in data from ethnic minorities in genomic cohorts and data sets, and supporting a new approach to cancer diagnosis.
Hancock explained that new support for the UK Functional Genomics Initiative will drive new approaches to improve our understanding of how genetic changes cause disease. Genomics sequencing will be used as part of everyday diagnosis and treatment, giving doctors the tools to make better clinical […]